Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia

Biology of the Neonate

Volumn 87, Issue 2, 2005, Pages 82-90

  Kakkera, Deepika K ^b   Siddiq, Mustafa M ^b   Parton, Lance A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

Bronchopulmonary dysplasia; Interleukin 1; Prematurity

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR AGONIST; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

AIRWAY; ARTICLE; ARTIFICIAL VENTILATION; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LEUKOCYTE; LUNG DYSPLASIA; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS SYNDROME; TRACHEA;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LUNG; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SIALOGLYCOPROTEINS; SUCTION; TRACHEA;

EID: 14044273591     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081504     Document Type: Article

References (38)

1. Arend WP: The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002; 13: 323-340.
2. Romero R, Sepulveda W, Mazor M, Brandt F, Cotton DB, Dinarello CA, Mitchell MD: The natural interleukin-1 receptor antagonist in term and preterm parturition. Am J Obstet Gynecol 1992; 167: 863-872.
3. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C: The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996; 125: 191-196.
4. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P: Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159: 487-494.
5. Robbins PD, Evans CH, Chernajovsky Y: Gene therapy for arthritis. Gene Ther 2003; 10: 902-911.
6. Cunnane G, Madigan A, Murphy E, FitzGerald O, Bresnihan B: The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheumatology 2001; 40: 62-69.
7. Ikejima T, Okusawa S, Ghezzi P, van der Meer JW, Dinarello CA: Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis 1990; 162: 215-223.
8. Dinarello CA, Ikejima T, Warner SJ, Orencole SF, Lonnemann G, Cannon JG, Libby P: Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 1987; 139: 1902-1910.
9. Shalaby MR, Waage A, Aarden L, Espevik T: Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989; 53: 488-498.
10. Niu JO, Munshi UK, Siddiq MM, Parton LA: Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 1998; 132: 965-970.
11. Munshi UK, Niu JO, Siddiq MM, Parton LA: Elevation of Interleukin-8 and Interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997; 24: 331-336.
12. Kakkera D, Parton LA: Elevation of the proinflammatory cytokine interleukin 1 in tracheal aspirates from preterm infants who progress to bronchopulmonary dysplasia. Pediatr Res 1999; 45: 203A.
13. Kakkera DK, Siddiq MM, Parton LA: Bronchopulmonary dysplasia (BPD): impaired expression of interleukin-1 receptor antagonist (IL1Ra). Pediatr Res 2004; abstract, submitted.
14. Kakkera DK, Siddiq MM, Parton LA: Impaired interleukin-1 receptor antagonist (IL1Ra) response in the first week of life leads to bronchopulmonary dysplasia (BPD) in preterm infants with respiratory distress syndrome (RDS). Am J Respir Crit Care Med 2004; abstract, submitted.
15. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
16. Singhal KK, Parton LA: Plasminogen activator activity in preterm infants with respiratory distress syndrome: Relationship to the development of bronchopulmonary dysplasia. Pediatr Res 1996; 39: 229-235.
17. Malyak M, Guthridge JM, Hance KR, Dower SK, Freed JH, Arend WP: Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J Immunol 1998; 161: 1997-2003.
18. Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-113.
19. Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167-227.
20. Lennard AC: Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15: 77-105.
21. Malyak M, Swaney RE, Arend WP: Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: potential contribution from synovial fluid neutrophils. Arthritis Rheum 1993; 36: 781-789.
22. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL: Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992; 79: 2196-2200.
23. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP: Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994; 37: 644-652.
24. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC: Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993; 341: 146-148.
25. Smith DR, Kunkel SL, Standiford TJ, Rolfe MW, Lynch JP III, Arenberg DA, Wilke CA, Burdick MD, Martinez FJ, Hampton JN, Whyte RI, Orringer MB, Strieter RM: Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis: a compartmentalized analysis. Am J Respir Crit Care Med 1995; 151: 1965-1973.
26. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P: Balance of I1-1 receptor antagonis/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995; 154: 1432-1439.
27. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, Thompson RC, Dinarello CA: Interleukin-1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990; 86: 972-980.
28. Joosten LA, Helsen MM, van de Loo FA, van den Berg WB: Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNFa, anti-IL-1a/b, and IL-1Ra. Arthritis Rheum 1996; 39: 797-809.
29. Dinarello CA: Interleukin-1; in Thomson A (ed): The Cytokine Handbook, ed 3. San Diego, Academic Press, 1998, pp 35-72.
30. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975.
31. Rozycki HJ: Bronchoalveolar interleukin-1β in infants on day 1 of life. South Med J 1994; 87: 991-996.
32. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215.
33. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI: Amniotic fluid cytokines (IL-6, TNF-α, IL-1β and IL-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825-830.
34. Rindfleisch MS, Hasday JD, Taciak V, Broderick K, Viscardi RM: Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res 1996; 16: 365-373.
35. Arend WP, Welgus HG, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990; 85: 1694-1697.
36. Elias JA, Zitnik RJ: Cytokine-cytokine interactions in the context of cytokine networking. Am J Respir Cell Mol Biol 1992; 7: 365-367.
37. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F II, Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164: 1896-1903.
38. Dargaville PA, South M, Vervaart P, McDougall PN: Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999; 160: 778-784.